Stephen P. Carey sold $265k of ANIP
SVP & CFO at ANI PHARMACEUTICALS INC. 3,312 shares at an average of $80.00, traded Jun 5, 2026, filed Jun 9, 2026.
Score components
- +22RoleCFO
- +13Trade size$265k at market
- 0Share of holdings soldSold 1.8% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001674236-26-000013, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | MOption exercise Common Stock10b5-1 | +3,312 | $49.51 | $164k | 183,705 | Jun 9, 2026 |
| Jun 5, 2026 | SOpen-market sale Common Stock10b5-1 | -3,312 | $80.00 | $265k | 180,393 | Jun 9, 2026 |
| Jun 5, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,312 | $49.51 | $164k | 6,626 | Jun 9, 2026 |
Related signals
Other insiders at ANI PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $208k 2,850 shares | -2% | |
| 36Weak | ANI PHARMACEUTICALS INC | Nikhil Lalwani PRESIDENT & CEO | $383k 5,400 shares | -2% | |
| 18Weak | ANI PHARMACEUTICALS INC | Jeanne Thoma director | $72k 1,000 shares | -4% | |
| 16Weak | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $35k 500 shares | -1% | |
| 29Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $207k 2,850 shares | -2% | |
| 15Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $240k 2,850 shares | -2% | |
| 16Weak | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $41k 500 shares | -1% | |
| 21Weak | ANI PHARMACEUTICALS INC | Thomas Haughey director | $162k 2,000 shares | -5% | |
| 36Weak | ANI PHARMACEUTICALS INC | Thomas Andrew Rowland SVP, HEAD - ESTABLISHED BRANDS | $36k 459 shares | -1% | |
| 65Notable | ANI PHARMACEUTICALS INC | Patrick D Walsh director | $1.1M 13,973 shares | -27% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.